Mumbai: Unichem Labs has announced that the United States Food and Drug Administration (USFDA) has successfully concluded inspection without any observation at the Company's Ghaziabad (Uttar Pradesh) formulation facility. Unichem Labs stated in a BSE filing. Unichem Labs stated in a BSE filing. Read also: Unichem Labs bags USFDA nod for hypertension drug DoxazosinHeadquartered in Mumbai, Unichem Laboratories Limited is an international, integrated, specialty pharmaceutical company. Read also: USFDA nod to Unichem Labs Prasugrel Tablets to reduce thrombotic CV events rate in acute coronary syndrome